Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 8:11:1268799.
doi: 10.3389/fpubh.2023.1268799. eCollection 2023.

Prevalence of depressive symptoms and correlates among individuals who self-reported SARS-CoV-2 infection after optimizing the COVID-19 response in China

Liangjia Wei #  1 , Jiao Qin #  1 , Zhifeng Lin #  1 , Xinju Huang  1 , Jinfeng He  1 , Dee Yu  2 , Fei Zhang  1 , Sisi Li  1 , Ping Cen  3 , Mu Li  1 , Tong Luo  1 , Rongjing Zhang  1 , Shanmei Zhong  1 , Cai Qin  1 , Zeyu Li  1 , Yuan Yang  1 , Huiqi Pan  1 , Mengdi Zhao  1 , Xiaoqiong Wu  1 , Junjun Jiang  1   4 , Hao Liang  1   4 , Li Ye  1   4 , Bingyu Liang  1   4
Affiliations

Prevalence of depressive symptoms and correlates among individuals who self-reported SARS-CoV-2 infection after optimizing the COVID-19 response in China

Liangjia Wei et al. Front Public Health. .

Abstract

Background: The burden of depression symptoms has increased among individuals infected with SARS-CoV-2 during COVID-19 pandemic. However, the prevalence and associated factors of depressive symptoms among individuals infected with SARS-CoV-2 remain uncertain after optimizing the COVID-19 response in China.

Methods: An online cross-sectional survey was conducted among the public from January 6 to 30, 2023, using a convenience sampling method. Sociodemographic and COVID-19 pandemic-related factors were collected. The depression symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9). Logistic regression analysis was performed to explore the associated factors with depressive symptoms.

Results: A total of 2,726 participants completed the survey. The prevalence of depression symptoms was 35.3%. About 58% of the participants reported experiencing insufficient drug supply. More than 40% of participants reported that they had missed healthcare appointments or delayed treatment. One-third of participants responded experiencing a shortage of healthcare staff and a long waiting time during medical treatment. Logistic regression analysis revealed several factors that were associated with depression symptoms, including sleep difficulties (OR, 2.84; 95% CI, 2.34-3.44), chronic diseases (OR, 2.15; 95% CI, 1.64-2.82), inpatient treatment for COVID-19 (OR, 3.24; 95% CI, 2.19-4.77), with COVID-19 symptoms more than 13 days (OR, 1.30, 95% CI 1.04-1.63), re-infection with SARS-CoV-2 (OR, 1.52; 95% CI, 1.07-2.15), and the increased in demand for healthcare services (OR, 1.32; 95% CI, 1.08-1.61).

Conclusion: This study reveals a moderate prevalence of depression symptoms among individuals infected with SARS-CoV-2. The findings underscore the importance of continued focus on depressive symptoms among vulnerable individuals, including those with sleeping difficulties, chronic diseases, and inpatient treatment for COVID-19. It is necessary to provide mental health services and psychological interventions for these vulnerable groups during the COVID-19 epidemic.

Keywords: COVID-19; PHQ-9 scale; depressive symptoms; healthcare services; optimizing the COVID-19 response.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Study subjects flowchart.
Figure 2
Figure 2
Self-reported COVID-19 Symptoms among participants and main symptoms for inpatient treatment. (A) The self-reported COVID-19 symptoms among participants. (B) The main symptoms for inpatient treatment. In the legend, “Yes” indicates the presence of the symptom, and “No” represents the absence of the symptom.
Figure 3
Figure 3
Barriers to accessing healthcare services and reasons for delayed or canceled medical appointments after optimizing the COVID-19 response in China. (A) Barriers to accessing healthcare services. (B) The reasons for delaying or canceling medical appointments.
See this image and copyright information in PMC

References

    1. Fong TCT, Chang K, Ho RTH. Association between quarantine and sleep disturbance in Hong Kong adults: the mediating role of COVID-19 mental impact and distress. Front Psychiatry. (2023) 14:1127070. 10.3389/fpsyt.2023.1127070 - DOI - PMC - PubMed
    1. Mooldijk SS, Dommershuijsen LJ, de Feijter M, Luik AI. Trajectories of depression and anxiety during the COVID-19 pandemic in a population-based sample of middle-aged and older adults. J Psychiatr Res. (2022) 149:274–80. 10.1016/j.jpsychires.2022.03.002 - DOI - PMC - PubMed
    1. Motrico E, Dominguez-Salas S, Rodriguez-Dominguez C, Gomez-Gomez I, Rodriguez-Munoz MF, Gomez-Baya D. The impact of the COVID-19 pandemic on perinatal depression and anxiety: a large cross-sectional study in Spain. Psicothema. (2022) 34:200–8. 10.7334/psicothema2021.380 - DOI - PubMed
    1. Benke C, Autenrieth LK, Asselmann E, Pane-Farre CA. Stay-at-home orders due to the COVID-19 pandemic are associated with elevated depression and anxiety in younger, but not older adults: results from a nationwide community sample of adults from Germany. Psychol Med. (2020) 2:1–2. 10.1017/S0033291720003438 - DOI - PMC - PubMed
    1. Liao YH, Fan BF, Zhang HM, Guo L, Lee Y, Wang WX, et al. . The impact of COVID-19 on subthreshold depressive symptoms: a longitudinal study. Epidemiol Psychiatr Sci. (2021) 30:e20. 10.1017/S2045796021000044 - DOI - PMC - PubMed

Publication types